Relay Therapeutics, Inc. (RLAY) short interest & options flow
NASDAQRelay Therapeutics heads into its Q2 earnings release tonight with a striking divergence: short sellers have been covering aggressively, even as the analyst community has turned unanimously bullish. The short-interest picture tells the clearest story. Bearish positioning has collapsed by roughly 15% over the past month, dropping from a peak near 47 million shares in mid-July to…
RLAY short interest surges 21.2% in a week to 26.3% of float, driven by clinical-stage biotech volatility and bearish positioning ahead of pipeline catalysts.
- Market cap
- $3.95B
- Next earnings
- 5 Nov 2026
Key data as of 5 Nov 2026
Latest signals on RLAY
- Short Interest
RLAY short interest surges 21.2% in a week to 26.3% of float, driven by clinical-stage biotech volatility and bearish positioning ahead of pipeline catalysts.
RLAY news and analysis
RSSNo long-form analysis yet for RLAY. Pulse alerts and the live data picture are available on ORTEX.
Open RLAY on ORTEX →Want the live picture for RLAY?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RLAY — free to start on ORTEX.
Sign up for free →Open RLAY on ORTEX